Lantheus Holdings, Inc. Amortization of Intangible Assets
Lantheus Holdings, Inc. (LNTH) reported Amortization of Intangible Assets of $33.40 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AmortizationOfIntangibleAssets · last filed 2026-08-06
- Lantheus Holdings, Inc. amortization of intangible assets for the quarter ending 2026-06-30 was $16.70M, a 108.75% increase year-over-year.
- Lantheus Holdings, Inc. amortization of intangible assets for the quarter ending 2026-03-31 was $16.70M, a 108.75% increase year-over-year.
- Lantheus Holdings, Inc. amortization of intangible assets for the quarter ending 2025-12-31 was $16.50M, a 39.83% increase year-over-year.
- Lantheus Holdings, Inc. amortization of intangible assets for the quarter ending 2025-09-30 was $14.60M, a 22.69% increase year-over-year.
- Lantheus Holdings, Inc. amortization of intangible assets for fiscal 2025 was $47.10M, a 7.53% increase from fiscal 2024.
- Lantheus Holdings, Inc. amortization of intangible assets for fiscal 2024 was $43.80M, a 5.60% decline from fiscal 2023.
- Lantheus Holdings, Inc. amortization of intangible assets for fiscal 2023 was $46.40M, a 39.76% increase from fiscal 2022.
- Lantheus Holdings, Inc. amortization of intangible assets for fiscal 2022 was $33.20M, a 20.73% increase from fiscal 2021.
| Period end | Amortization of Intangible Assets 3 month | Amortization of Intangible Assets 6 month | Amortization of Intangible Assets 9 month | Amortization of Intangible Assets 12 month |
|---|---|---|---|---|
| 2026-06-30 | $16.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $33.40M 10-Q · filed 2026-08-06 | $49.90M derived: sum of 3 quarters · filed 2026-08-06 | $64.50M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $16.70M 10-Q · filed 2026-08-06 | $33.20M derived: sum of 2 quarters · filed 2026-08-06 | $47.80M derived: sum of 3 quarters · filed 2026-08-06 | $55.80M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $16.50M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $31.10M derived: sum of 2 quarters · filed 2026-02-26 | $39.10M derived: sum of 3 quarters · filed 2026-08-06 | $47.10M 10-K · filed 2026-02-26 |
| 2025-09-30 | $14.60M 10-Q · filed 2025-11-06 | $22.60M derived: sum of 2 quarters · filed 2026-08-06 | $30.60M 10-Q · filed 2025-11-06 | $42.40M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $8.00M 10-Q · filed 2026-08-06 | $16.00M 10-Q · filed 2026-08-06 | $27.80M derived: sum of 3 quarters · filed 2026-08-06 | $39.70M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $8.00M 10-Q · filed 2026-05-07 | $19.80M derived: sum of 2 quarters · filed 2026-05-07 | $31.70M derived: sum of 3 quarters · filed 2026-05-07 | $41.90M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $11.80M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $23.70M derived: sum of 2 quarters · filed 2026-02-26 | $33.90M derived: sum of 3 quarters · filed 2026-02-26 | $43.80M 10-K · filed 2026-02-26 |
| 2024-09-30 | $11.90M 10-Q · filed 2025-11-06 | $22.10M derived: sum of 2 quarters · filed 2025-11-06 | $32.00M 10-Q · filed 2025-11-06 | $43.30M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | $10.20M 10-Q · filed 2025-08-06 | $20.10M 10-Q · filed 2025-08-06 | $31.40M derived: sum of 3 quarters · filed 2026-02-26 | $43.10M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | $9.90M 10-Q · filed 2025-05-07 | $21.20M derived: sum of 2 quarters · filed 2026-02-26 | $32.90M derived: sum of 3 quarters · filed 2026-02-26 | $45.30M derived: sum of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | $11.30M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $23.00M derived: sum of 2 quarters · filed 2026-02-26 | $35.40M derived: sum of 3 quarters · filed 2026-02-26 | $46.40M 10-K · filed 2026-02-26 |
| 2023-09-30 | $11.70M 10-Q · filed 2024-11-06 | $24.10M derived: sum of 2 quarters · filed 2024-11-06 | $35.10M 10-Q · filed 2024-11-06 | $43.50M derived: sum of 4 quarters · filed 2025-02-26 |
| 2023-06-30 | $12.40M 10-Q · filed 2024-07-31 | $23.50M 10-Q · filed 2024-07-31 | $31.80M derived: sum of 3 quarters · filed 2025-02-26 | $40.10M derived: sum of 4 quarters · filed 2025-02-26 |
| 2023-03-31 | $11.10M 10-Q · filed 2024-05-02 | $19.40M derived: sum of 2 quarters · filed 2025-02-26 | $27.70M derived: sum of 3 quarters · filed 2025-02-26 | $36.00M derived: sum of 4 quarters · filed 2025-02-26 |
| 2022-12-31 | $8.30M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-26 | $16.60M derived: sum of 2 quarters · filed 2025-02-26 | $24.90M derived: sum of 3 quarters · filed 2025-02-26 | $33.20M 10-K · filed 2025-02-26 |
| 2022-09-30 | $8.30M 10-Q · filed 2023-11-02 | $16.60M derived: sum of 2 quarters · filed 2023-11-02 | $24.90M 10-Q · filed 2023-11-02 | $33.30M derived: sum of 4 quarters · filed 2024-02-22 |
| 2022-06-30 | $8.30M 10-Q · filed 2023-08-03 | $16.60M 10-Q · filed 2023-08-03 | $25.00M derived: sum of 3 quarters · filed 2024-02-22 | $33.40M derived: sum of 4 quarters · filed 2024-02-22 |
| 2022-03-31 | $8.30M 10-Q · filed 2023-05-04 | $16.70M derived: sum of 2 quarters · filed 2024-02-22 | $25.10M derived: sum of 3 quarters · filed 2024-02-22 | $31.20M derived: sum of 4 quarters · filed 2024-02-22 |
| 2021-12-31 | $8.40M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | $16.80M derived: sum of 2 quarters · filed 2024-02-22 | $22.90M derived: sum of 3 quarters · filed 2024-02-22 | $27.50M 10-K · filed 2024-02-22 |
| 2021-09-30 | $8.40M 10-Q · filed 2022-11-03 | $14.50M derived: sum of 2 quarters · filed 2022-11-03 | $19.10M 10-Q · filed 2022-11-03 | $23.90M derived: sum of 4 quarters · filed 2023-02-23 |
| 2021-06-30 | $6.10M 10-Q · filed 2022-08-04 | $10.80M 10-Q · filed 2022-08-04 | $15.50M derived: sum of 3 quarters · filed 2023-02-23 | $20.30M derived: sum of 4 quarters · filed 2023-02-23 |
| 2021-03-31 | $4.70M 10-Q · filed 2022-04-29 | $9.40M derived: sum of 2 quarters · filed 2023-02-23 | $14.20M derived: sum of 3 quarters · filed 2023-02-23 | $15.10M derived: sum of 4 quarters · filed 2023-02-23 |
| 2020-12-31 | $4.70M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | $9.50M derived: sum of 2 quarters · filed 2023-02-23 | $10.40M derived: sum of 3 quarters · filed 2023-02-23 | $10.80M 10-K · filed 2023-02-23 |
| 2020-09-30 | $4.80M 10-Q · filed 2021-11-04 | $5.70M derived: sum of 2 quarters · filed 2021-11-04 | $6.10M 10-Q · filed 2021-11-04 | $6.50M derived: sum of 4 quarters · filed 2022-02-24 |
| 2020-06-30 | $900.00K 10-Q · filed 2021-07-28 | $1.30M 10-Q · filed 2021-07-28 | $1.70M derived: sum of 3 quarters · filed 2022-02-24 | $2.20M derived: sum of 4 quarters · filed 2022-02-24 |
| 2020-03-31 | $400.00K 10-Q · filed 2021-05-04 | $800.00K derived: sum of 2 quarters · filed 2022-02-24 | $1.30M derived: sum of 3 quarters · filed 2022-02-24 | $1.80M derived: sum of 4 quarters · filed 2022-02-24 |
| 2019-12-31 | $400.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $900.00K derived: sum of 2 quarters · filed 2022-02-24 | $1.40M derived: sum of 3 quarters · filed 2022-02-24 | $1.80M 10-K · filed 2022-02-24 |
| 2019-09-30 | $500.00K 10-Q · filed 2020-11-05 | $1.00M derived: sum of 2 quarters · filed 2020-11-05 | $1.40M 10-Q · filed 2020-11-05 | |
| 2019-06-30 | $500.00K 10-Q · filed 2020-07-31 | $900.00K 10-Q · filed 2020-07-31 | ||
| 2018-12-31 | $2.60M 10-K · filed 2021-02-25 | |||
| 2017-12-31 | $3.30M 10-K · filed 2020-02-25 | |||
| 2016-12-31 | $1.20M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-20 | $2.50M derived: sum of 2 quarters · filed 2019-02-20 | $3.80M derived: sum of 3 quarters · filed 2019-02-20 | $5.10M 10-K · filed 2019-02-20 |
| 2016-09-30 | $1.30M 10-Q · filed 2016-11-01 | $2.60M derived: sum of 2 quarters · filed 2016-11-01 | $3.90M 10-Q · filed 2016-11-01 | $5.40M derived: sum of 4 quarters · filed 2018-02-26 |
| 2016-06-30 | $1.30M 10-Q · filed 2016-08-04 | $2.60M 10-Q · filed 2016-08-04 | $4.10M derived: sum of 3 quarters · filed 2018-02-26 | $5.60M derived: sum of 4 quarters · filed 2018-02-26 |
| 2016-03-31 | $1.30M 10-Q · filed 2016-05-03 | $2.80M derived: sum of 2 quarters · filed 2018-02-26 | $4.30M derived: sum of 3 quarters · filed 2018-02-26 | $5.80M derived: sum of 4 quarters · filed 2018-02-26 |
| 2015-12-31 | $1.50M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-26 | $3.00M derived: sum of 2 quarters · filed 2018-02-26 | $4.50M derived: sum of 3 quarters · filed 2018-02-26 | $6.00M 10-K · filed 2018-02-26 |
| 2015-09-30 | $1.50M 10-Q · filed 2016-11-01 | $3.00M derived: sum of 2 quarters · filed 2016-11-01 | $4.50M 10-Q · filed 2016-11-01 | $6.40M derived: sum of 4 quarters · filed 2017-02-23 |
| 2015-06-30 | $1.50M 10-Q · filed 2016-08-04 | $3.00M 10-Q · filed 2016-08-04 | $4.90M derived: sum of 3 quarters · filed 2017-02-23 | $6.80M derived: sum of 4 quarters · filed 2017-02-23 |
| 2015-03-31 | $1.50M 10-Q · filed 2016-05-03 | $3.40M derived: sum of 2 quarters · filed 2017-02-23 | $5.30M derived: sum of 3 quarters · filed 2017-02-23 | $7.20M derived: sum of 4 quarters · filed 2017-02-23 |
| 2014-12-31 | $1.90M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-23 | $3.80M derived: sum of 2 quarters · filed 2017-02-23 | $5.70M derived: sum of 3 quarters · filed 2017-02-23 | $7.60M 10-K · filed 2017-02-23 |
| 2014-09-30 | $1.90M 10-Q · filed 2015-11-04 | $3.80M derived: sum of 2 quarters · filed 2015-11-04 | $5.70M 10-Q · filed 2015-11-04 | |
| 2014-06-30 | $1.90M 10-Q · filed 2015-08-05 | $3.80M 10-Q · filed 2015-08-05 | ||
| 2013-12-31 | $14.40M 10-K · filed 2016-03-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B |